Retour

Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference

Calendar Calendar of Events

NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company's chief medical officer and executive vice president, will participate in a fireside at Bank of America’s 2024 Healthcare Conference on Tuesday, May 14, 2024, at 1:40 p.m. PT.

GlobeNewswire Inc. • 07/05/2024 à 22:30:00
Ultragenyx Pharmaceutical Inc.
Address: 60 LEVERONI COURT
Postal Code: 94949
City: NOVATO
State: CA
Phone Number: 415-483-8800
Website: https://www.ultragenyx.com
Status: Active
Company Info

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

List Date2014-01-31
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001515673
Composite figiBBG001RWPDW6
Share Class figiBBG001V2MJJ2
Market Cap3,480,792,988 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees1276
Share Class Shares Outstanding83130000
Weighted Shares Outstanding83133341
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
41.646
43.2
41.12
40.945
40.855
Variance
-3.6%
5.06%
0.37%
0.22%
1.4%
Open
43.2
41.12
40.97
40.855
40.29
Highest
43.2
43.86
41.795
41.525
41.949
Lowest
43.2
43.86
41.795
41.525
41.931
History
PeriodVarhighestlowest
1 week
3.37%
41.949
41.525
1 month
0.13%
44.62
41.329
3 month
-3.34%
49.909
41.329
6 month
3.83%
40.4
37.21
1 year
-18.72%
52.105
31.52
3 year
-62.03%
112.78
31.52
5 year
-31.71%
60.98
31.52
10 year
21.81%
36.02
31.52
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-04 2023-11-03 UNPUB
Assets 1,383,404,000 1,311,310,000 1,238,140,000 UNPUB
Current Assets 766,336,000 702,137,000 599,188,000 UNPUB
Current Liabilities 218,179,000 244,379,000 253,978,000 UNPUB
Equity 220,481,000 129,030,000 31,714,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 220,481,000 129,030,000 31,714,000 UNPUB
Liabilities 1,162,923,000 1,182,280,000 1,206,426,000 UNPUB
Liabilities And Equity 1,383,404,000 1,311,310,000 1,238,140,000 UNPUB
Noncurrent Assets 617,068,000 609,173,000 638,952,000 UNPUB
Noncurrent Liabilities 944,744,000 937,901,000 952,448,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-04 2023-11-03 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -46,285,000 16,277,000 -28,345,000 UNPUB
Net Cash Flow, Continuing -46,285,000 16,277,000 -28,345,000 UNPUB
Net Cash Flow From Financing Activities -722,000 33,020,000 25,234,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -722,000 33,020,000 25,234,000 UNPUB
Net Cash Flow From Investing Activities 111,304,000 99,418,000 64,295,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 111,304,000 99,418,000 64,295,000 UNPUB
Net Cash Flow From Operating Activities -156,867,000 -116,161,000 -117,874,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -156,867,000 -116,161,000 -117,874,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-04 2023-11-03 UNPUB
Comprehensive Income/Loss -161,366,000 -158,959,000 -158,795,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -161,366,000 -158,959,000 -158,795,000 UNPUB
Other Comprehensive Income/Loss 2,606,000 869,000 854,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-04 2023-11-03 UNPUB
Basic Earnings Per Share -2 -2 -2 UNPUB
Benefits Costs and Expenses 263,973,000 267,405,000 257,051,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 263,973,000 267,405,000 257,051,000 UNPUB
Diluted Earnings Per Share -2 -2 -2 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -163,972,000 -159,828,000 -159,649,000 UNPUB
Income/Loss From Continuing Operations Before Tax -163,477,000 -159,096,000 -158,999,000 UNPUB
Income Tax Expense/Benefit 495,000 732,000 650,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -163,972,000 -159,828,000 -159,649,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -163,972,000 -159,828,000 -159,649,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -163,972,000 -159,828,000 -159,649,000 UNPUB
Operating Expenses 254,601,000 256,266,000 243,149,000 UNPUB
Operating Income/Loss -154,105,000 -147,957,000 -145,097,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 100,496,000 108,309,000 98,052,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-06 2022-07-29 2022-11-03 2023-02-17
Assets 1,384,029,000 1,320,627,000 1,618,474,000 1,545,444,000
Current Assets 707,519,000 678,542,000 1,012,668,000 883,899,000
Current Liabilities 167,231,000 220,636,000 227,361,000 261,210,000
Equity 796,424,000 678,073,000 468,829,000 352,494,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 796,424,000 678,073,000 468,829,000 352,494,000
Liabilities 587,605,000 642,554,000 1,149,645,000 1,192,950,000
Liabilities And Equity 1,384,029,000 1,320,627,000 1,618,474,000 1,545,444,000
Noncurrent Assets 676,510,000 642,085,000 605,806,000 661,545,000
Noncurrent Liabilities 0 0 922,284,000 931,740,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-06 2022-07-29 2022-11-03 2023-02-17
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -153,271,000 7,748,000 234,673,000 -170,909,000
Net Cash Flow, Continuing -153,271,000 7,748,000 234,673,000 -170,909,000
Net Cash Flow From Financing Activities 1,612,000 5,837,000 491,877,000 501,208,000
Net Cash Flow From Financing Activities, Continuing 1,612,000 5,837,000 491,877,000 501,208,000
Net Cash Flow From Investing Activities -37,362,000 79,168,000 -161,859,000 -291,652,000
Net Cash Flow From Investing Activities, Continuing -37,362,000 79,168,000 -161,859,000 -291,652,000
Net Cash Flow From Operating Activities -117,521,000 -77,257,000 -95,345,000 -380,465,000
Net Cash Flow From Operating Activities, Continuing -117,521,000 -77,257,000 -95,345,000 -380,465,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-06 2022-07-29 2022-11-03 2023-02-17
Comprehensive Income/Loss -157,470,000 -160,522,000 -246,414,000 -712,590,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -157,470,000 -160,522,000 -246,414,000 -712,590,000
Other Comprehensive Income/Loss -5,150,000 -2,360,000 -1,308,000 -5,169,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-06 2022-07-29 2022-11-03 2023-02-17
Basic Earnings Per Share UNPUB UNPUB -4 -10
Benefits Costs and Expenses 231,697,000 247,203,000 329,522,000 1,065,054,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 231,697,000 247,203,000 329,522,000 1,065,054,000
Diluted Earnings Per Share UNPUB UNPUB -4 -10
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -152,320,000 -158,162,000 -245,106,000 -707,421,000
Income/Loss From Continuing Operations Before Tax -151,762,000 -157,860,000 -238,819,000 -701,725,000
Income Tax Expense/Benefit 558,000 302,000 6,287,000 5,696,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -152,320,000 -158,162,000 -245,106,000 -707,421,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -152,320,000 -158,162,000 -245,106,000 -707,421,000
Net Income/Loss Available To Common Stockholders, Basic -152,320,000 -158,162,000 -245,106,000 -707,421,000
Operating Expenses 216,567,000 230,936,000 315,769,000 1,012,248,000
Operating Income/Loss -136,632,000 -141,593,000 -225,066,000 -648,919,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 79,935,000 89,343,000 90,703,000 363,329,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-03 2022-02-15
Assets 1,597,763,000 1,512,444,000 1,484,801,000 1,522,397,000
Current Assets 1,070,936,000 949,492,000 846,884,000 856,604,000
Current Liabilities 127,044,000 127,067,000 135,933,000 181,368,000
Equity 1,054,582,000 972,171,000 933,674,000 922,561,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,054,582,000 972,171,000 933,674,000 922,561,000
Liabilities 543,181,000 540,273,000 551,127,000 599,836,000
Liabilities And Equity 1,597,763,000 1,512,444,000 1,484,801,000 1,522,397,000
Noncurrent Assets 526,827,000 562,952,000 637,917,000 665,793,000
Noncurrent Liabilities 0 0 415,194,000 418,468,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-03 2022-02-15
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -329,121,000 -93,974,000 -92,858,000 -415,515,000
Net Cash Flow, Continuing -329,121,000 -93,974,000 -92,858,000 -415,515,000
Net Cash Flow From Financing Activities 12,649,000 12,628,000 7,550,000 118,552,000
Net Cash Flow From Financing Activities, Continuing 12,649,000 12,628,000 7,550,000 118,552,000
Net Cash Flow From Investing Activities -182,424,000 -41,246,000 -40,759,000 -195,372,000
Net Cash Flow From Investing Activities, Continuing -182,424,000 -41,246,000 -40,759,000 -195,372,000
Net Cash Flow From Operating Activities -159,346,000 -65,356,000 -59,649,000 -338,695,000
Net Cash Flow From Operating Activities, Continuing -159,346,000 -65,356,000 -59,649,000 -338,695,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-03 2022-02-15
Comprehensive Income/Loss -136,774,000 -122,252,000 -73,176,000 -456,118,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -136,774,000 -122,252,000 -73,176,000 -456,118,000
Other Comprehensive Income/Loss -633,000 176,000 -178,000 -2,093,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-03 2022-02-15
Basic Earnings Per Share -2 -2 UNPUB UNPUB
Benefits Costs and Expenses 235,157,000 208,940,000 154,463,000 804,387,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 235,157,000 208,940,000 154,463,000 804,387,000
Diluted Earnings Per Share -2 -2 UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -136,141,000 -122,428,000 -72,998,000 -454,025,000
Income/Loss From Continuing Operations Before Tax -135,762,000 -121,965,000 -72,816,000 -452,981,000
Income Tax Expense/Benefit 379,000 463,000 182,000 1,044,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -136,141,000 -122,428,000 -72,998,000 -454,025,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -136,141,000 -122,428,000 -72,998,000 -454,025,000
Net Income/Loss Available To Common Stockholders, Basic -136,141,000 -122,428,000 -72,998,000 -454,025,000
Operating Expenses 205,964,000 169,751,000 171,475,000 733,143,000
Operating Income/Loss -106,569,000 -82,776,000 -89,828,000 -381,737,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 99,395,000 86,975,000 81,647,000 351,406,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-07-30 2020-10-27 2021-02-12
Assets 1,233,140,000 1,314,041,000 1,268,385,000 1,759,555,000
Current Assets 894,318,000 906,039,000 872,003,000 1,295,304,000
Current Liabilities 196,858,000 219,729,000 201,186,000 189,609,000
Equity 609,146,000 695,587,000 666,191,000 1,154,375,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 609,146,000 695,587,000 666,191,000 1,154,375,000
Liabilities 623,994,000 618,454,000 602,194,000 605,180,000
Liabilities And Equity 1,233,140,000 1,314,041,000 1,268,385,000 1,759,555,000
Noncurrent Assets 338,822,000 408,002,000 396,382,000 464,251,000
Noncurrent Liabilities 0 0 401,008,000 415,571,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-07-30 2020-10-27 2021-02-12
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -134,662,000 37,023,000 -138,590,000 288,931,000
Net Cash Flow, Continuing -134,662,000 37,023,000 -138,590,000 288,931,000
Net Cash Flow From Financing Activities 55,615,000 35,811,000 19,135,000 600,272,000
Net Cash Flow From Financing Activities, Continuing 55,615,000 35,811,000 19,135,000 600,272,000
Net Cash Flow From Investing Activities -95,125,000 -86,139,000 -95,758,000 -179,121,000
Net Cash Flow From Investing Activities, Continuing -95,125,000 -86,139,000 -95,758,000 -179,121,000
Net Cash Flow From Operating Activities -95,152,000 87,351,000 -61,967,000 -132,220,000
Net Cash Flow From Operating Activities, Continuing -95,152,000 87,351,000 -61,967,000 -132,220,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-07-30 2020-10-27 2021-02-12
Comprehensive Income/Loss -119,025,000 25,315,000 -68,845,000 -185,730,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -120,423,000 28,144,000 -69,116,000 -185,730,000
Other Comprehensive Income/Loss -1,398,000 2,829,000 -271,000 836,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-07-30 2020-10-27 2021-02-12
Basic Earnings Per Share -2 0 -1 -3
Benefits Costs and Expenses 0 0 0 456,389,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 156,974,000 124,764,000 131,785,000 456,389,000
Diluted Earnings Per Share -2 0 -1 -3
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -119,025,000 25,315,000 -68,845,000 -186,566,000
Income/Loss From Continuing Operations Before Tax -118,616,000 25,730,000 -68,532,000 -185,359,000
Income Tax Expense/Benefit 409,000 415,000 313,000 1,207,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -119,025,000 25,315,000 -68,845,000 -186,566,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -119,025,000 25,315,000 -68,845,000 -186,566,000
Net Income/Loss Available To Common Stockholders, Basic -119,025,000 25,315,000 -68,845,000 -186,566,000
Operating Expenses 156,974,000 124,764,000 131,785,000 601,146,000
Operating Income/Loss -120,665,000 -63,055,000 -50,315,000 -330,116,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 36,309,000 61,709,000 81,470,000 271,030,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-02 2019-11-06 2020-02-14
Assets 1,007,759,000 958,927,000 879,944,000 1,135,496,000
Current Assets 786,887,000 699,431,000 613,486,000 851,017,000
Current Liabilities 66,880,000 75,006,000 90,307,000 103,300,000
Equity 886,729,000 819,787,000 727,265,000 653,764,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 886,729,000 819,787,000 727,265,000 653,764,000
Liabilities 121,030,000 139,140,000 152,679,000 481,732,000
Liabilities And Equity 1,007,759,000 958,927,000 879,944,000 1,135,496,000
Noncurrent Assets 220,872,000 259,496,000 266,458,000 284,479,000
Noncurrent Liabilities 0 0 62,372,000 378,432,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-02 2019-11-06 2020-02-14
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 156,649,000 -138,147,000 -8,288,000 320,884,000
Net Cash Flow, Continuing 156,649,000 -138,147,000 -8,288,000 320,884,000
Net Cash Flow From Financing Activities 353,617,000 9,342,000 904,000 679,306,000
Net Cash Flow From Financing Activities, Continuing 353,617,000 9,342,000 904,000 679,306,000
Net Cash Flow From Investing Activities -101,193,000 -58,426,000 79,314,000 -13,039,000
Net Cash Flow From Investing Activities, Continuing -101,193,000 -58,426,000 79,314,000 -13,039,000
Net Cash Flow From Operating Activities -95,775,000 -89,063,000 -88,506,000 -345,383,000
Net Cash Flow From Operating Activities, Continuing -95,775,000 -89,063,000 -88,506,000 -345,383,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-02 2019-11-06 2020-02-14
Comprehensive Income/Loss -96,756,000 -99,172,000 -112,994,000 -402,241,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -96,271,000 -98,769,000 -113,320,000 -402,241,000
Other Comprehensive Income/Loss 485,000 403,000 -326,000 486,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-02 2019-11-06 2020-02-14
Basic Earnings Per Share -2 UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 503,158,000
Cost Of Revenue 452,000 766,000 UNPUB UNPUB
Costs And Expenses 117,386,000 136,623,000 143,833,000 503,158,000
Diluted Earnings Per Share -2 UNPUB UNPUB UNPUB
Gross Profit 17,720,000 23,383,000 UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -96,756,000 -99,172,000 -112,994,000 -402,727,000
Income/Loss From Continuing Operations Before Tax -96,540,000 -98,959,000 -112,701,000 -399,444,000
Income Tax Expense/Benefit 216,000 213,000 293,000 3,283,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -96,756,000 -99,172,000 -112,994,000 -402,727,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -96,756,000 -99,172,000 -112,994,000 -402,727,000
Net Income/Loss Available To Common Stockholders, Basic -96,756,000 -99,172,000 -112,994,000 -402,727,000
Operating Expenses 117,386,000 136,623,000 143,833,000 527,887,000
Operating Income/Loss -99,214,000 -112,474,000 -118,033,000 -424,173,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 18,172,000 24,149,000 25,800,000 103,714,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-03 2018-11-06 2019-02-20
Assets 817,350,000 806,022,000 765,145,000 719,558,000
Current Assets 581,580,000 604,743,000 567,480,000 522,369,000
Current Liabilities 57,583,000 66,049,000 66,681,000 74,725,000
Equity 723,657,000 703,971,000 662,596,000 608,908,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 723,657,000 703,971,000 662,596,000 608,908,000
Liabilities 93,693,000 102,051,000 102,549,000 110,650,000
Liabilities And Equity 817,350,000 806,022,000 765,145,000 719,558,000
Noncurrent Assets 235,770,000 201,279,000 197,665,000 197,189,000
Noncurrent Liabilities 36,110,000 36,002,000 35,868,000 35,925,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-03 2018-11-06 2019-02-20
Exchange Gains/Losses 249,000 UNPUB UNPUB UNPUB
Net Cash Flow 126,162,000 -115,228,000 -27,928,000 12,956,000
Net Cash Flow, Continuing 125,913,000 -114,979,000 -27,928,000 12,956,000
Net Cash Flow From Financing Activities 286,419,000 13,168,000 25,024,000 336,853,000
Net Cash Flow From Financing Activities, Continuing 286,419,000 13,168,000 25,024,000 336,853,000
Net Cash Flow From Investing Activities -71,028,000 -52,069,000 16,205,000 -33,331,000
Net Cash Flow From Investing Activities, Continuing -71,028,000 -52,069,000 16,205,000 -33,331,000
Net Cash Flow From Operating Activities -89,478,000 -76,078,000 -69,157,000 -290,566,000
Net Cash Flow From Operating Activities, Continuing -89,478,000 -76,078,000 -69,157,000 -290,566,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-03 2018-11-06 2019-02-20
Comprehensive Income/Loss 30,253,000 -52,728,000 -87,310,000 -192,564,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 34,987,000 -52,436,000 -87,066,000 -192,564,000
Other Comprehensive Income/Loss 4,734,000 292,000 244,000 5,047,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-03 2018-11-06 2019-02-20
Basic Earnings Per Share 1 -1 -2 -4
Benefits Costs and Expenses 0 0 0 248,592,000
Cost Of Revenue 225,000 141,000 273,000 1,146,000
Costs And Expenses 107,164,000 107,694,000 101,409,000 248,592,000
Diluted Earnings Per Share 1 -1 -2 -4
Gross Profit 10,452,000 12,653,000 11,490,000 50,349,000
Income/Loss From Continuing Operations After Tax 30,253,000 -52,728,000 -87,310,000 -197,611,000
Income/Loss From Continuing Operations Before Tax 30,292,000 -52,626,000 -87,063,000 -197,097,000
Income Tax Expense/Benefit 39,000 102,000 247,000 514,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 30,253,000 -52,728,000 -87,310,000 -197,611,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 30,253,000 -52,728,000 -87,310,000 -197,611,000
Net Income/Loss Available To Common Stockholders, Basic 30,253,000 -52,728,000 -87,310,000 -197,611,000
Operating Expenses 107,164,000 107,694,000 101,409,000 422,868,000
Operating Income/Loss -96,487,000 -94,900,000 -89,646,000 -371,373,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 10,677,000 12,794,000 11,763,000 51,495,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-07-28 2017-11-03 2018-02-21
Assets 545,822,000 497,542,000 435,047,000 490,753,000
Current Assets 444,685,000 419,794,000 390,903,000 269,583,000
Current Liabilities 51,755,000 62,675,000 64,261,000 71,014,000
Equity 488,478,000 429,453,000 365,558,000 383,454,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 488,478,000 429,453,000 365,558,000 383,454,000
Liabilities 57,344,000 68,089,000 69,489,000 107,299,000
Liabilities And Equity 545,822,000 497,542,000 435,047,000 490,753,000
Noncurrent Assets 101,137,000 77,748,000 44,144,000 221,170,000
Noncurrent Liabilities 5,589,000 5,414,000 5,228,000 36,285,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-07-28 2017-11-03 2018-02-21
Exchange Gains/Losses 17,000 -378,000 528,000 528,000
Net Cash Flow -1,619,000 -68,750,000 -30,344,000 -60,632,000
Net Cash Flow, Continuing -1,636,000 -68,372,000 -30,872,000 -61,160,000
Net Cash Flow From Financing Activities 68,969,000 1,526,000 1,333,000 136,267,000
Net Cash Flow From Financing Activities, Continuing 68,969,000 1,526,000 1,333,000 136,267,000
Net Cash Flow From Investing Activities -9,400,000 -21,076,000 29,788,000 56,416,000
Net Cash Flow From Investing Activities, Continuing -9,400,000 -21,076,000 29,788,000 56,416,000
Net Cash Flow From Operating Activities -61,205,000 -48,822,000 -61,993,000 -253,843,000
Net Cash Flow From Operating Activities, Continuing -61,205,000 -48,822,000 -61,993,000 -253,843,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-07-28 2017-11-03 2018-02-21
Comprehensive Income/Loss -68,290,000 -72,891,000 -79,227,000 -308,724,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -68,964,000 -77,345,000 -82,408,000 -308,724,000
Other Comprehensive Income/Loss -674,000 -4,454,000 -3,181,000 -6,585,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-07-28 2017-11-03 2018-02-21
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB 0 320,950,000
Cost Of Revenue UNPUB UNPUB UNPUB 1,000
Costs And Expenses UNPUB UNPUB 83,911,000 320,950,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB 2,611,000
Income/Loss From Continuing Operations After Tax -68,290,000 -72,891,000 -79,227,000 -302,139,000
Income/Loss From Continuing Operations Before Tax -68,290,000 -72,877,000 -79,223,000 -318,338,000
Income Tax Expense/Benefit 0 14,000 4,000 -16,199,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -68,290,000 -72,891,000 -79,227,000 -302,139,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -68,290,000 -72,891,000 -79,227,000 -302,139,000
Net Income/Loss Available To Common Stockholders, Basic -68,290,000 -72,891,000 -79,227,000 -302,139,000
Operating Expenses 69,954,000 78,441,000 83,911,000 331,554,000
Operating Income/Loss -69,954,000 -78,441,000 -83,713,000 -328,942,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 198,000 2,612,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-08 2017-02-17
Assets 524,184,000 481,951,000 515,166,000 540,626,000
Current Assets 430,234,000 411,084,000 416,785,000 401,695,000
Current Liabilities 29,880,000 31,983,000 50,431,000 60,259,000
Equity 489,824,000 443,895,000 455,890,000 473,974,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 489,824,000 443,895,000 455,890,000 473,974,000
Liabilities 34,360,000 38,056,000 59,276,000 66,652,000
Liabilities And Equity 524,184,000 481,951,000 515,166,000 540,626,000
Noncurrent Assets 93,950,000 70,867,000 98,381,000 138,931,000
Noncurrent Liabilities 4,480,000 6,073,000 8,845,000 6,393,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-08 2017-02-17
Exchange Gains/Losses UNPUB UNPUB UNPUB -65,000
Net Cash Flow -22,806,000 -15,694,000 87,211,000 67,551,000
Net Cash Flow, Continuing -22,806,000 -15,694,000 87,211,000 67,616,000
Net Cash Flow From Financing Activities 314,000 -25,000 63,447,000 138,676,000
Net Cash Flow From Financing Activities, Continuing 314,000 -25,000 63,447,000 138,676,000
Net Cash Flow From Investing Activities 21,775,000 23,986,000 52,509,000 89,915,000
Net Cash Flow From Investing Activities, Continuing 21,775,000 23,986,000 52,509,000 89,915,000
Net Cash Flow From Operating Activities -44,895,000 -39,655,000 -28,745,000 -160,975,000
Net Cash Flow From Operating Activities, Continuing -44,895,000 -39,655,000 -28,745,000 -160,975,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-08 2017-02-17
Comprehensive Income/Loss -52,757,000 -56,923,000 -64,907,000 -244,101,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -51,797,000 -56,763,000 -65,147,000 -244,101,000
Other Comprehensive Income/Loss 0 160,000 -240,000 1,773,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-08 2017-02-17
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 245,972,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 53,622,000 58,070,000 65,894,000 245,972,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -52,757,000 -56,923,000 -64,907,000 -245,874,000
Income/Loss From Continuing Operations Before Tax -52,757,000 17,000 111,000 -245,839,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 35,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -52,757,000 -56,923,000 -64,907,000 -245,874,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -52,757,000 -56,923,000 -64,907,000 -245,874,000
Net Income/Loss Available To Common Stockholders, Basic -52,757,000 -56,923,000 -64,907,000 -245,874,000
Operating Expenses 53,622,000 58,070,000 65,894,000 248,140,000
Operating Income/Loss -53,622,000 -58,053,000 -65,783,000 -248,007,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 17,000 111,000 133,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-14 2015-11-10 2016-02-26
Assets 355,840,000 343,004,000 602,130,000 559,569,000
Current Assets 350,514,000 336,530,000 460,707,000 450,207,000
Current Liabilities 14,243,000 23,042,000 24,733,000 27,918,000
Equity 341,119,000 319,278,000 576,763,000 531,090,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 341,119,000 319,278,000 576,763,000 531,090,000
Liabilities 14,721,000 23,726,000 25,367,000 28,479,000
Liabilities And Equity 355,840,000 343,004,000 602,130,000 559,569,000
Noncurrent Assets 5,326,000 6,474,000 141,423,000 109,362,000
Noncurrent Liabilities 478,000 684,000 634,000 561,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-14 2015-11-10 2016-02-26
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 153,716,000 -125,689,000 114,335,000 69,245,000
Net Cash Flow, Continuing 153,716,000 -125,689,000 114,335,000 69,245,000
Net Cash Flow From Financing Activities 175,440,000 2,595,000 288,651,000 467,573,000
Net Cash Flow From Financing Activities, Continuing 175,440,000 2,595,000 288,651,000 467,573,000
Net Cash Flow From Investing Activities -4,065,000 -111,011,000 -143,715,000 -292,351,000
Net Cash Flow From Investing Activities, Continuing -4,065,000 -111,011,000 -143,715,000 -292,351,000
Net Cash Flow From Operating Activities -17,659,000 -17,273,000 -30,601,000 -105,977,000
Net Cash Flow From Operating Activities, Continuing -17,659,000 -17,273,000 -30,601,000 -105,977,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-14 2015-11-10 2016-02-26
Comprehensive Income/Loss -21,379,000 -29,787,000 -39,232,000 -146,312,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -21,299,000 -29,902,000 -39,062,000 -146,312,000
Other Comprehensive Income/Loss 0 0 0 -146,312,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-14 2015-11-10 2016-02-26
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,379,000 -29,787,000 -39,232,000 -145,618,000
Income/Loss From Continuing Operations Before Tax -21,379,000 -29,787,000 -39,232,000 -145,618,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -21,379,000 -29,787,000 -39,232,000 -145,618,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,379,000 -29,787,000 -39,232,000 -145,618,000
Net Income/Loss Available To Common Stockholders, Basic -21,379,000 -29,787,000 -39,232,000 -145,618,000
Operating Expenses 21,502,000 30,142,000 39,936,000 147,738,000
Operating Income/Loss -21,502,000 -30,142,000 -39,936,000 -147,738,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-11 2014-11-10 2015-03-27
Assets 172,707,000 162,586,000 210,931,000 197,967,000
Current Assets 169,636,000 158,216,000 206,741,000 193,416,000
Current Liabilities 6,811,000 8,943,000 11,072,000 12,517,000
Equity 165,714,000 153,083,000 199,326,000 184,945,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 165,714,000 153,083,000 199,326,000 184,945,000
Liabilities 6,993,000 9,503,000 11,605,000 13,022,000
Liabilities And Equity 172,707,000 162,586,000 210,931,000 197,967,000
Noncurrent Assets 3,071,000 4,370,000 4,190,000 4,551,000
Noncurrent Liabilities 182,000 560,000 533,000 505,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-11 2014-11-10 2015-03-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 48,020,000 -37,995,000 35,935,000 16,897,000
Net Cash Flow, Continuing 0 0 0 16,897,000
Net Cash Flow From Financing Activities 121,754,000 10,000 60,510,000 184,971,000
Net Cash Flow From Financing Activities, Continuing 121,754,000 10,000 60,510,000 184,971,000
Net Cash Flow From Investing Activities -65,398,000 -27,476,000 -13,545,000 -123,440,000
Net Cash Flow From Investing Activities, Continuing -113,418,000 10,519,000 -49,480,000 -123,440,000
Net Cash Flow From Operating Activities -8,336,000 -10,529,000 -11,030,000 -44,634,000
Net Cash Flow From Operating Activities, Continuing -8,336,000 -10,529,000 -11,030,000 -44,634,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-11 2014-11-10 2015-03-27
Comprehensive Income/Loss -13,630,000 -13,585,000 -15,849,000 -59,987,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -13,687,000 -13,587,000 -15,919,000 -59,987,000
Other Comprehensive Income/Loss 0 0 0 -59,987,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-11 2014-11-10 2015-03-27
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 10,432,000 13,810,000 UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -13,630,000 -13,585,000 -15,849,000 -59,802,000
Income/Loss From Continuing Operations Before Tax -13,630,000 -13,585,000 -15,849,000 -59,802,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -13,630,000 -13,585,000 -15,849,000 -59,802,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -13,630,000 -13,585,000 -15,849,000 -59,802,000
Net Income/Loss Available To Common Stockholders, Basic -18,438,000 -13,585,000 -15,849,000 -64,610,000
Operating Expenses 10,339,000 13,661,000 15,835,000 56,778,000
Operating Income/Loss -10,339,000 -13,661,000 -15,835,000 -56,778,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 4,808,000 0 0 4,808,000
Preferred Stock Dividends And Other Adjustments 4,808,000 0 0 4,808,000
Revenues 93,000 149,000 0 0
Calendar
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:RARE240517P00060000 OPASPS Put American 100 60 BATO 2024-05-17
O:RARE240517P00055000 OPASPS Put American 100 55 BATO 2024-05-17
O:RARE240517P00050000 OPASPS Put American 100 50 BATO 2024-05-17
O:RARE240517P00045000 OPASPS Put American 100 45 BATO 2024-05-17
O:RARE240517P00040000 OPASPS Put American 100 40 BATO 2024-05-17
O:RARE240517P00035000 OPASPS Put American 100 35 BATO 2024-05-17
O:RARE240517P00030000 OPASPS Put American 100 30 BATO 2024-05-17
O:RARE240517P00025000 OPASPS Put American 100 25 BATO 2024-05-17
O:RARE240517P00022500 OPASPS Put American 100 22.5 BATO 2024-05-17
O:RARE240517C00060000 OCASPS Call American 100 60 BATO 2024-05-17
O:RARE240517C00055000 OCASPS Call American 100 55 BATO 2024-05-17
O:RARE240517C00050000 OCASPS Call American 100 50 BATO 2024-05-17
O:RARE240517C00045000 OCASPS Call American 100 45 BATO 2024-05-17
O:RARE240517C00040000 OCASPS Call American 100 40 BATO 2024-05-17
O:RARE240517C00035000 OCASPS Call American 100 35 BATO 2024-05-17
O:RARE240517C00030000 OCASPS Call American 100 30 BATO 2024-05-17
O:RARE240517C00025000 OCASPS Call American 100 25 BATO 2024-05-17
O:RARE240517C00022500 OCASPS Call American 100 22.5 BATO 2024-05-17
O:RARE240517P00070000 OPASPS Put American 100 70 BATO 2024-05-17
O:RARE240517P00065000 OPASPS Put American 100 65 BATO 2024-05-17
O:RARE240517C00070000 OCASPS Call American 100 70 BATO 2024-05-17
O:RARE240517C00065000 OCASPS Call American 100 65 BATO 2024-05-17
O:RARE240517P00080000 OPASPS Put American 100 80 BATO 2024-05-17
O:RARE240517P00075000 OPASPS Put American 100 75 BATO 2024-05-17
O:RARE240517C00080000 OCASPS Call American 100 80 BATO 2024-05-17
O:RARE240517C00075000 OCASPS Call American 100 75 BATO 2024-05-17
O:RARE240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:RARE240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:RARE240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:RARE240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:RARE240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:RARE240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:RARE240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:RARE240419C00065000 OCASPS Call American 100 65 BATO 2024-04-19
O:RARE240419C00060000 OCASPS Call American 100 60 BATO 2024-04-19
O:RARE240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:RARE240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:RARE240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:RARE240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:RARE240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:RARE240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:RARE240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:RARE240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:RARE240419P00075000 OPASPS Put American 100 75 BATO 2024-04-19
O:RARE240419P00070000 OPASPS Put American 100 70 BATO 2024-04-19
O:RARE240419C00075000 OCASPS Call American 100 75 BATO 2024-04-19
O:RARE240419C00070000 OCASPS Call American 100 70 BATO 2024-04-19
O:RARE240419P00065000 OPASPS Put American 100 65 BATO 2024-04-19
O:RARE240419P00060000 OPASPS Put American 100 60 BATO 2024-04-19
O:RARE240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:RARE240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:RARE240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:RARE240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:RARE240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:RARE240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:RARE240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:RARE240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:RARE240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:RARE240315P00070000 OPASPS Put American 100 70 BATO 2024-03-15
O:RARE240315P00065000 OPASPS Put American 100 65 BATO 2024-03-15
O:RARE240315P00060000 OPASPS Put American 100 60 BATO 2024-03-15
O:RARE240315P00055000 OPASPS Put American 100 55 BATO 2024-03-15
O:RARE240315P00050000 OPASPS Put American 100 50 BATO 2024-03-15
O:RARE240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:RARE240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:RARE240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:RARE240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:RARE240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:RARE240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:RARE240315C00070000 OCASPS Call American 100 70 BATO 2024-03-15
O:RARE240315C00065000 OCASPS Call American 100 65 BATO 2024-03-15
O:RARE240315C00060000 OCASPS Call American 100 60 BATO 2024-03-15
O:RARE240315C00055000 OCASPS Call American 100 55 BATO 2024-03-15
O:RARE240315C00050000 OCASPS Call American 100 50 BATO 2024-03-15
O:RARE240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:RARE240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:RARE240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:RARE240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:RARE240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:RARE240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:RARE240216P00075000 OPASPS Put American 100 75 BATO 2024-02-16
O:RARE240216P00070000 OPASPS Put American 100 70 BATO 2024-02-16
O:RARE240216P00065000 OPASPS Put American 100 65 BATO 2024-02-16
O:RARE240216P00060000 OPASPS Put American 100 60 BATO 2024-02-16
O:RARE240216P00055000 OPASPS Put American 100 55 BATO 2024-02-16
O:RARE240216P00050000 OPASPS Put American 100 50 BATO 2024-02-16
O:RARE240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:RARE240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:RARE240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:RARE240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:RARE240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:RARE240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:RARE240216C00075000 OCASPS Call American 100 75 BATO 2024-02-16
O:RARE240216C00070000 OCASPS Call American 100 70 BATO 2024-02-16
O:RARE240216C00065000 OCASPS Call American 100 65 BATO 2024-02-16
O:RARE240216C00060000 OCASPS Call American 100 60 BATO 2024-02-16
O:RARE240216C00055000 OCASPS Call American 100 55 BATO 2024-02-16
O:RARE240216C00050000 OCASPS Call American 100 50 BATO 2024-02-16
O:RARE240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:RARE240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:RARE240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:RARE240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:RARE240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:RARE240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:RARE240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:RARE240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:RARE240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:RARE240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:RARE240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:RARE240119P00075000 OPASPS Put American 100 75 BATO 2024-01-19
O:RARE240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:RARE240119P00070000 OPASPS Put American 100 70 BATO 2024-01-19
O:RARE240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:RARE240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:RARE240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:RARE240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:RARE240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:RARE240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:RARE240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:RARE240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:RARE240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:RARE240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:RARE240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:RARE240119C00075000 OCASPS Call American 100 75 BATO 2024-01-19
O:RARE240119C00070000 OCASPS Call American 100 70 BATO 2024-01-19
O:RARE240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:RARE240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:RARE240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:RARE240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:RARE240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:RARE240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:RARE240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:RARE240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:RARE240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:RARE240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:RARE240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:RARE231215P00055000 OPASPS Put American 100 55 BATO 2023-12-15
O:RARE231215P00050000 OPASPS Put American 100 50 BATO 2023-12-15
O:RARE231215P00045000 OPASPS Put American 100 45 BATO 2023-12-15
O:RARE231215P00040000 OPASPS Put American 100 40 BATO 2023-12-15
O:RARE231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:RARE231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:RARE231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:RARE231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:RARE231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:RARE231215C00075000 OCASPS Call American 100 75 BATO 2023-12-15
O:RARE231215C00070000 OCASPS Call American 100 70 BATO 2023-12-15
O:RARE231215C00065000 OCASPS Call American 100 65 BATO 2023-12-15
O:RARE231215C00060000 OCASPS Call American 100 60 BATO 2023-12-15
O:RARE231215C00055000 OCASPS Call American 100 55 BATO 2023-12-15
O:RARE231215C00050000 OCASPS Call American 100 50 BATO 2023-12-15
O:RARE231215C00045000 OCASPS Call American 100 45 BATO 2023-12-15
O:RARE231215C00040000 OCASPS Call American 100 40 BATO 2023-12-15
O:RARE231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:RARE231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:RARE231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:RARE231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:RARE231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:RARE231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:RARE231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:RARE231215P00075000 OPASPS Put American 100 75 BATO 2023-12-15
O:RARE231215P00070000 OPASPS Put American 100 70 BATO 2023-12-15
O:RARE231215P00065000 OPASPS Put American 100 65 BATO 2023-12-15
O:RARE231215P00060000 OPASPS Put American 100 60 BATO 2023-12-15
O:RARE231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:RARE231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:RARE231117P00075000 OPASPS Put American 100 75 BATO 2023-11-17
O:RARE231117P00070000 OPASPS Put American 100 70 BATO 2023-11-17
O:RARE231117P00065000 OPASPS Put American 100 65 BATO 2023-11-17
O:RARE231117P00060000 OPASPS Put American 100 60 BATO 2023-11-17
O:RARE231117P00055000 OPASPS Put American 100 55 BATO 2023-11-17
O:RARE231117P00050000 OPASPS Put American 100 50 BATO 2023-11-17
O:RARE231117P00045000 OPASPS Put American 100 45 BATO 2023-11-17
O:RARE231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:RARE231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:RARE231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:RARE231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:RARE231117P00022500 OPASPS Put American 100 22.5 BATO 2023-11-17
O:RARE231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:RARE231117C00075000 OCASPS Call American 100 75 BATO 2023-11-17
O:RARE231117C00070000 OCASPS Call American 100 70 BATO 2023-11-17
O:RARE231117C00065000 OCASPS Call American 100 65 BATO 2023-11-17
O:RARE231117C00060000 OCASPS Call American 100 60 BATO 2023-11-17
O:RARE231117C00055000 OCASPS Call American 100 55 BATO 2023-11-17
O:RARE231117C00050000 OCASPS Call American 100 50 BATO 2023-11-17
O:RARE231117C00045000 OCASPS Call American 100 45 BATO 2023-11-17
O:RARE231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:RARE231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:RARE231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:RARE231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:RARE231117C00022500 OCASPS Call American 100 22.5 BATO 2023-11-17
O:RARE231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:RARE231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:RARE231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:RARE231020P00070000 OPASPS Put American 100 70 BATO 2023-10-20
O:RARE231020P00065000 OPASPS Put American 100 65 BATO 2023-10-20
O:RARE231020P00060000 OPASPS Put American 100 60 BATO 2023-10-20
O:RARE231020P00055000 OPASPS Put American 100 55 BATO 2023-10-20
O:RARE231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:RARE231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:RARE231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:RARE231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:RARE231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:RARE231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:RARE231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:RARE231020C00070000 OCASPS Call American 100 70 BATO 2023-10-20
O:RARE231020C00065000 OCASPS Call American 100 65 BATO 2023-10-20
O:RARE231020C00060000 OCASPS Call American 100 60 BATO 2023-10-20
O:RARE231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:RARE231020C00055000 OCASPS Call American 100 55 BATO 2023-10-20
O:RARE231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:RARE231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:RARE231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:RARE231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:RARE231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:RARE231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:RARE231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:RARE231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:RARE230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:RARE230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:RARE230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:RARE230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:RARE230915P00065000 OPASPS Put American 100 65 BATO 2023-09-15
O:RARE230915P00060000 OPASPS Put American 100 60 BATO 2023-09-15
O:RARE230915P00055000 OPASPS Put American 100 55 BATO 2023-09-15
O:RARE230915P00050000 OPASPS Put American 100 50 BATO 2023-09-15
O:RARE230915P00045000 OPASPS Put American 100 45 BATO 2023-09-15
O:RARE230915P00040000 OPASPS Put American 100 40 BATO 2023-09-15
O:RARE230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:RARE230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:RARE230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:RARE230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:RARE230915C00065000 OCASPS Call American 100 65 BATO 2023-09-15
O:RARE230915C00060000 OCASPS Call American 100 60 BATO 2023-09-15
O:RARE230915C00055000 OCASPS Call American 100 55 BATO 2023-09-15
O:RARE230915C00050000 OCASPS Call American 100 50 BATO 2023-09-15
O:RARE230915C00045000 OCASPS Call American 100 45 BATO 2023-09-15
O:RARE230915C00040000 OCASPS Call American 100 40 BATO 2023-09-15
O:RARE230818P00075000 OPASPS Put American 100 75 BATO 2023-08-18
O:RARE230818P00070000 OPASPS Put American 100 70 BATO 2023-08-18
O:RARE230818P00065000 OPASPS Put American 100 65 BATO 2023-08-18
O:RARE230818P00060000 OPASPS Put American 100 60 BATO 2023-08-18
O:RARE230818P00055000 OPASPS Put American 100 55 BATO 2023-08-18
O:RARE230818P00050000 OPASPS Put American 100 50 BATO 2023-08-18
O:RARE230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:RARE230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:RARE230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:RARE230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:RARE230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:RARE230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:RARE230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:RARE230818C00075000 OCASPS Call American 100 75 BATO 2023-08-18
O:RARE230818C00070000 OCASPS Call American 100 70 BATO 2023-08-18
O:RARE230818C00065000 OCASPS Call American 100 65 BATO 2023-08-18
O:RARE230818C00060000 OCASPS Call American 100 60 BATO 2023-08-18
O:RARE230818C00055000 OCASPS Call American 100 55 BATO 2023-08-18
O:RARE230818C00050000 OCASPS Call American 100 50 BATO 2023-08-18
O:RARE230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:RARE230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:RARE230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:RARE230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:RARE230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:RARE230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
O:RARE230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
News Stream
Stocks Changes in company's own shares
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 17,180 restricted stock units of the company’s common stock to ten newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of May 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire Inc. • 1d ago
Calendar Calendar of Events
Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company's chief medical officer and executive vice president, will participate in a fireside at Bank of America’s 2024 Healthcare Conference on Tuesday, May 14, 2024, at 1:40 p.m. PT.
GlobeNewswire Inc. • 1w ago
Stocks Earnings Releases and Operating Results
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million
GlobeNewswire Inc. • 2w ago
Stocks Company Announcement
Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease
NOVATO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today released its 2023 Corporate Responsibility Report, which showcases the company’s efforts to transform the lives of individuals and families impacted by rare and ultrarare diseases, empower its employees, and make a meaningful impact on the communities it partners with.
GlobeNewswire Inc. • 2w ago
Calendar Calendar of Events
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, May 2, 2024, to discuss its financial results and corporate update for the quarter ending March 31, 2024.
GlobeNewswire Inc. • 3w ago
Stocks Stock Market News
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 44,965 restricted stock units of the company’s common stock to 14 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of April 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire Inc. • 4w ago
Calendar Calendar of Events
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
Conference call now scheduled for Monday, April 15 at 8:00 a.m. ET
GlobeNewswire Inc. • 1mo ago
News Conference Calls/ Webcasts
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
Company will host investor call on April 17 at 8:00 a.m. ET to discuss new data from GTX-102 Phase 1/2 clinical study in patients with Angelman syndrome Company will host investor call on April 17 at 8:00 a.m. ET to discuss new data from GTX-102 Phase 1/2 clinical study in patients with Angelman syndrome
GlobeNewswire Inc. • 1mo ago
Analyst Analyst Ratings
Expert Outlook: Ultragenyx Pharmaceutical Through The Eyes Of 9 Analysts
Analysts' ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 7 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 1 3 1 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $94.33, a high estimate of $114.00, and a low estimate of $48.00. This current average reflects an increase of 22.19% from the previous average price target of $77.20. Deciphering Analyst Ratings: An In-Depth Analysis In examining recent analyst actions, we gain insights into how financial experts perceive Ultragenyx Pharmaceutical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Kristen Kluska Cantor Fitzgerald Maintains Overweight $107.00 - Anupam Rama JP Morgan Raises Overweight $92.00 $88.00 Cory Kasimov JP Morgan Raises Overweight $88.00 $84.00 Kristen Kluska Cantor Fitzgerald Announces Overweight $107.00 - Whitney Ijem Canaccord Genuity Raises Buy $111.00 $110.00 Laura Chico Wedbush Raises Neutral $48.00 $47.00 Kristen Kluska Cantor Fitzgerald Maintains Overweight $114.00 - Joel Beatty Baird Raises Outperform $68.00 $57.00 Kristen Kluska Cantor Fitzgerald Maintains Overweight $114.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related ...Full story available on Benzinga.com
Benzinga • 1mo ago
Stocks Stock Market News
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 13,020 restricted stock units of the company’s common stock to eight newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of March 18, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire Inc. • 1mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT